Should I buy Salesforce (CRM) stock or is it too late?

Salesforce · Information Technology · price $238

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: BTIG — 82% of its targets hit on this sector (71 calls tested). It aims for $300 (+26 %), call made on September 3, 2026, maturing on September 3, 2027 (41 d ago).

The 26 reliable analysts $285+20 %

The 4 other firms $305+28 %

How to read it: the 26 reliable firms are not filtered by optimism — 22 aim above the price, 4 below, hence their $285 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Salesforce

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Wells Fargo	86 %	+28.4 %	14	$250 +5%
Citigroup	89 %	+25.6 %	9	$263 +10%
Wedbush	68 %	+21.0 %	22	$325 +37%
Macquarie	100 %	+21.0 %	8	$225 -5%
Barclays	70 %	+17.0 %	37	$276 +16%
Evercore ISI Group	70 %	+16.6 %	10	$290 +22%
RBC Capital	64 %	+14.7 %	22	$250 +5%
Canaccord Genuity	67 %	+13.9 %	24	$300 +26%

In short — Should you invest in Salesforce? Is it too late, still worth it? Analysts are fairly positive (67% buy, median target $285, i.e. +20%). But the stock is volatile. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

67% of analysts rate it a buy (Buy consensus, 33 ratings) — a sign of market conviction.
Median price target $285, i.e. +20% from the current price ($238).
17 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.

⚠️ Reasons to hesitate

Even the most reliable firm on CRM, DA Davidson (100% hit rate, 3 scored calls), only targets $200 (call made on August 27, 2026, maturing on August 27, 2027) (-16%) in its most recent call. The stock may already have run past its target.
The consensus is not unanimous: of 33 ratings, 10 are neutral and 1 is a sell.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
Volatile stock: sharp swings — including steep drops — are part of its profile.

The analyst consensus on CRM

Median target $285 (+20%) · 33 ratings · Buy consensus

Strong Buy00%

Buy2267%

Hold1030%

Sell13%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Salesforce now?

We won't decide for you. The facts: 67% of analysts rate it a buy, median target $285 (+20%), and DA Davidson (most reliable on CRM, 100%) targets $200. Weigh that against valuation (P/E ~22) and volatility. This is not personalized advice.

Is it too late to invest in Salesforce?

Not according to analysts: the median target ($285) is still +20% above the current price ($238) (most reliable on CRM: DA Davidson, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Salesforce still worth investing in?

It depends on the gap between the price ($238) and its estimated value: analysts target $285 on median (+20%), with 67% buys (most reliable on CRM: DA Davidson, 100%). Cross-check with their real reliability on CRM and the cautions above. Information, not advice.

What's the main risk in buying CRM?

Even the most reliable firm on CRM, DA Davidson (100% hit rate, 3 scored calls), only targets $200 (call made on August 27, 2026, maturing on August 27, 2027) (-16%) in its most recent call. The stock may already have run past its target.

→ Go deeper: the full Salesforce profile (consensus, analyst reliability, price target, performance).